Released on behalf of the SGO Education Committee’s Chemotherapy/Targeted Therapies Subcommittee, ‘Management of Chemotherapy Hypersensitivity Reactions and Desensitization: An SGO Clinical Practice Statement' was developed to help members and their multidisciplinary teams recognize, respond, and manage reactions to commonly utilized agents in gynecologic malignancies. In addition, it provides recommendations to help safely challenge this agent when appropriate, promoting the safe use of chemotherapeutic agents among all providers in the delivery process. 

Released in January 2023.  

Keywords: chemotherapy, hypersensitivity, targeted therapies, chemotherapy/targeted therapies subcommittee